These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27750147)

  • 1. Synthesis and evaluation of halogenated 12N-sulfonyl matrinic butanes as potential anti-coxsackievirus agents.
    Cheng XY; Li YH; Tang S; Zhang X; Wang YX; Wang SG; Jiang JD; Li YH; Song DQ
    Eur J Med Chem; 2017 Jan; 126():133-142. PubMed ID: 27750147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
    Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents.
    Li YH; Tang S; Li YH; Cheng XY; Zhang X; Wang YX; Su F; Song DQ
    Bioorg Med Chem Lett; 2017 Feb; 27(4):829-833. PubMed ID: 28109785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
    Tang S; Li YH; Cheng XY; Li YH; Wang HQ; Kong LY; Zhang X; Jiang JD; Song DQ
    Future Med Chem; 2016 Apr; 8(5):495-508. PubMed ID: 26867658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and biological evaluation of 12-N-benzenesulfonyl matrinic ether derivatives as anti-coxsackievirus B3 agents].
    Cheng XY; Tang S; Kong LY; Li YH; Song DQ
    Yao Xue Xue Bao; 2016 Apr; 51(4):606-12. PubMed ID: 29859656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of 12N-substituted Tricyclic Matrinic Derivatives as a Novel Family of Anti-Influenza Agents.
    Tang S; Li YH; Cheng XY; Yin JQ; Li YH; Song DQ; Wang YX; Liu ZD
    Med Chem; 2018; 14(8):764-772. PubMed ID: 29473520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
    Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
    ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
    Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
    Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against Coxsackievirus B.
    Zeng QX; Wang HQ; Wei W; Guo TT; Yu L; Wang YX; Li YH; Song DQ
    Bioorg Chem; 2020 Jan; 95():103490. PubMed ID: 31855821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel substituted 9-norbornylpurines and their activities against RNA viruses.
    Sála M; Hřebabecký H; Leyssen P; Dejmek M; Dračínský M; De Palma AM; Neyts J; Nencka R
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1963-8. PubMed ID: 22310228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolution of Pleconaril: Modified
    Volobueva A; Egorova A; Galochkina A; Ekins S; Zarubaev V; Makarov V
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32188089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis and anti-enteroviral activity of 9-arylpurines.
    Aguado L; Canela MD; Thibaut HJ; Priego EM; Camarasa MJ; Leyssen P; Neyts J; Pérez-Pérez MJ
    Eur J Med Chem; 2012 Mar; 49():279-88. PubMed ID: 22305341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral activities of synthetic glutarimide derivatives.
    Ji XY; Zhong ZJ; Xue ST; Meng S; He WY; Gao RM; Li YH; Li ZR
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1436-41. PubMed ID: 21048333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antiviral activity and structure-activity relationship of 1-(1-aryl-4,5-dihydro-1H-imidazoline)-3-chlorosulfonylureas and products of their cyclization.
    Rządkowska M; Szacoń E; Kaczor AA; Rajtar B; Świątek Ł; Polz-Dacewicz M; Matosiuk D
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):787-95. PubMed ID: 26212601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
    Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
    Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
    Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents.
    Tang S; Peng ZG; Li YH; Zhang X; Fan TY; Jiang JD; Wang YX; Song DQ
    Chem Cent J; 2017 Sep; 11(1):94. PubMed ID: 29086870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.